Breaking News, Collaborations & Alliances

Albumedix Extends Research Collaboration with Cobra Biologics

Collaboration investigates enhanced manufacturing of AAV and lentiviral vectors to improve quality and productivity for gene therapy and vaccine developers.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Albumedix has extended its research collaboration with Cobra Biologics, the gene therapy division of Cognate BioServices, a Charles River Laboratories International company. The research collaboration focuses on process optimization and stability enhancement in scale-up manufacturing of AAV and lentiviral vectors through Albumedix’ proprietary recombinant human albumin-based product.   Additionally, the collaboration aims to advance both up-stream and down-stream processing of AAV and lent...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters